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Abstract 
Objective: To collate data on women and cardiovascular disease in Australia and 
globally to inform public health campaigns and health care interventions.  
Design: Literature review 
Results:  
• Women with acute coronary syndromes show consistently poorer outcomes than 
men, independent of comorbidity and management, despite less anatomical 
obstruction of coronary arteries and relatively preserved left ventricular function. 
Higher mortality and complication rates are best documented among younger 
women and those with ST-segment-elevation myocardial infarction. 
• Sex differences in atherogenesis and cardiovascular adaptation have been 
hypothesised, but not proven. 
• Atrial fibrillation carries a relatively greater risk of stroke in women than in men, 
and anticoagulation therapy is associated with higher risk of bleeding 
complications. 
• The degree of risk conferred by single cardiovascular risk factors and combinations 
of risk factors may differ between the sexes, and marked postmenopausal changes 
are seen in some risk factors. 
• Sociocultural factors, delays in seeking care and differences in self-management 
behaviours may contribute to poorer outcomes in women. 
• Differences in clinical management for women, including higher rates of 
misdiagnosis and less aggressive treatment, have been reported, but there is a lack 
of evidence to determine their effects on outcomes, especially in angina. 
• Although enrolment of women in randomised clinical trials has increased since the 
1970s, women remain underrepresented in cardiovascular clinical trials. 
 
Conclusions: Improvement in the prevention and management of CVD in women will 
require a deeper understanding of women’s needs by the community, health care 
professionals, researchers and government. 
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Introduction 
Background 
Cardiovascular disease (CVD) is the leading cause of death and disability in 
Australian women (Australian Bureau of Statistics, 2009; Australian Institute of 
Health and Welfare, 2004, 2008). Coronary heart disease (CHD) ranks first among 
causes of death in Australian women (17.5% of deaths), followed by cerebrovascular 
disease (10.8%) (Australian Bureau of Statistics, 2009; Australian Institute of Health 
and Welfare, 2008).  In 2007, 61% of Australians who died from stroke, 60% of those 
who died from heart failure and 47% of those who died from CHD were women 
(Australian Bureau of Statistics, 2009). The 2004–2005 Australian Bureau of 
Statistics National Health Survey found a higher CVD prevalence in women (55%) 
than men (45%) (Australian Institute of Health and Welfare, 2008).  After adjusting 
for women’s relative longevity, about one in five Australian women has CVD, 
compared with about one in six men (Australian Institute of Health and Welfare, 
2008).  
 
Despite these statistics, most Australian women are unaware that heart disease is a 
major women’s health issue, (Guillemin, 2004)] and even those who have experienced 
an acute myocardial infarction (AMI) often fail to recognise their lifestyle risk factors 
(Worrall-Carter, et al., 2005) (Murphy et al., 2005). The Heart Foundation’s Go Red 
For Women campaign is raising awareness of CVD in women aged 40–65 years 
among the community, health professionals and researchers. These efforts are part of 
a long-term strategic program that aims to reduce CVD in women by promoting 
healthier lifestyles through smoking cessation, healthy eating and regular physical 
activity.   
 
Method 
We searched electronic databases (Cumulative Index of Nursing and Allied Health 
Literature, Medline, Embase, Science Direct and Scopus) using the following 
keywords: women, female, diagnostic techniques, cardiovascular disease, coronary 
heart disease, angioplasty, transluminal, percutaneous coronary, coronary artery 
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bypass, and myocardial revascularisation. We also conducted a web-based search 
using Google Scholar search engine and other strategies, and hand-searched articles 
and reports. We considered data from published peer-reviewed articles, unpublished 
and informally published literature. 
 
Findings 
Part A. Is women’s cardiovascular disease different? 
Coronary heart disease 
Prevalence and disease burden 
Almost one in four (18%) Australian women has CHD, compared with 30% of men 
(Australian Bureau of Statistics, 2006). Although the age-standardised prevalence of 
CHD is lower for women than men by about one-third,(Australian Institute of Health 
and Welfare, 2004) women’s longer life expectancy results in a higher prevalence for 
women in the over-75 age group (Australian Institute of Health and Welfare, 2004) . 
Coronary heart disease is the second highest contributor to disease burden (as 
measured by disability-adjusted life years) amongst Australian women, after anxiety 
and depression (Begg, Vos, Barker, Stanley, & Lopez, 2008). The prevalence and 
costs of CHD in Australian women are likely to increase in the near future (Access 
Economics, 2005). 
 
Outcomes 
In large United States (US)  studies, women with acute coronary syndromes (ACS) 
have shown consistently poorer short-term and long-term outcomes than men, 
independent of comorbidity and management (Ng, 2007) ( Roger et al., 2011). 
Compared with age-matched men, women with CHD experience higher rates of acute 
myocardial infarction (AMI)  and show higher rates of death due to CHD, despite 
apparently less anatomical obstruction of coronary arteries and relatively preserved 
left ventricular function (Shaw, Bugiardini, & Merz, 2009; Vaccarino, 2010).  
 
Studies among US women also suggest that they have a poorer prognosis than men 
after a first AMI (American Heart Association, 2008; Vaccarino, 2010). Among those 
aged 40 years and older, 23% women die within one year, compared with 23% of 
men. Approximately 35% of women who survive an AMI will have another within 6 
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years, compared with 18% of men, and 46% of women will be disabled with chronic 
heart failure (CHF) within 6 years, compared with only 22% of men. Women are 
almost twice as likely as men to die following cardiac bypass surgery (American 
Heart Association, 2008). These differences underscore the importance of targeted 
initiatives focussing on the specific needs of women (Mosca et al., 2011). 
 
Women’s poorer prognosis for CHD is partly due to older age at onset and associated 
higher rates of comorbidity. However, North American studies have reported higher 
mortality and morbidity rates in women post AMI after controlling for age, disease 
severity and comorbidity,(Vaccarino, 2010) and higher rates of fatal and nonfatal 
complications after thrombolytic therapy for AMI after adjusting for differences in 
age and presentation (Weaver et al., 1996). Women with CHD also report worse 
health-related quality of life than men (Norris et al., 2004). Sociodemographic factors 
may contribute to this increased disease burden. 
 
Overall, higher mortality and complication rates for ACS in women compared with 
men have been demonstrated mainly in two groups of women: the young to middle-
aged, and those with ST-segment-elevation MI (Vaccarino, 2010).The reasons for 
relatively higher risk in these groups are remain unknown (Vaccarino, 2010). 
 
Presentation and symptoms 
Women with CHD are more likely than men to present with unstable angina (Lerner 
& Kannel, 1986) or with non-ST-segment elevation ACS (Pilote et al., 2007). 
Although chest pain is the most common symptom of AMI in both sexes, atypical 
symptoms such as nausea and jaw pain may occur more often in women (Canto et al., 
2007; Kennedy et al., 1982; Milner et al., 1999). Women with CHD may perceive 
angina differently from men, and experience more chest pain during normal daily 
activities (Sheps et al., 2001) . 
 
Although women with CHD have more symptoms and physical limitations than men, 
studies in women with ACS or referred for revascularisation have reported less 
coronary artery obstruction (Vaccarino, 2010). Current evidence suggests that women 
are more likely than men to experience a syndrome of chest pain in the absence of 
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obstructive coronary artery disease, and that chest pain in women does not correlate 
with severity of stenosis (Vaccarino, 2010).  
 
Some investigators have hypothesised that these findings might be explained by sex 
differences in the pathophysiology of CHD, such as differences in intravascular 
remodelling in response to atherosclerotic plaque build-up, differences in patterns of 
plaque deposition, vasoconstriction due to coronary endothelial dysfunction, coronary 
microvascular disease, and global inflammation  (Bairey Merz et al., 2006; Blum & 
Blum, 2009; Shaw, et al., 2009; Vaccarino, 2010). Accordingly, standard perfusion 
studies to detect coronary artery stenosis might be less accurate in determining true 
cardiovascular risk in women (Bairey Merz, et al., 2006; Matyal, 2008).  However, 
the presence of vascular abnormalities in the absence of coronary artery obstruction 
has not been clearly demonstrated to be a more common cause of ischaemia in women 
than in men (Vaccarino, 2010). 
 
Heart failure 
Prevalence and disease burden 
There are no reliable prevalence statistics for chronic heart failure (CHF) in Australia. 
Based on 2004–2005 National Health Survey self-reports, approximately 1% of 
Australian women have CHF (Australian Institute of Health and Welfare, 2008).  
 
Outcomes 
Australian women are approximately 28% less likely than men to be hospitalised for 
heart failure (Australian Institute of Health and Welfare, 2004). However, heart 
failure is the principle cause of death for more women than men because women live 
longer (Australian Institute of Health and Welfare, 2008) (Teng et al., 2011). 
 
North American data show that overall, the probability of dying within 5 years of the 
diagnosis of CHF is approximately 50% for women and for men,(Pilote, et al., 2007) 
and overall survival times after a diagnosis of CHF are slightly longer for women than 
men (Pilote, et al., 2007).  However, the strong decline in heart failure death rates 
seen in men over the past 20 years have not been matched in women, ( Roger et al., 
2004) and the prevalence of clinically significant CHF among women is increasing 
(Pilote, et al., 2007). North American rates of hospitalisation due to heart failure has 
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increased more sharply in women than in men (Pilote, et al., 2007). Teng and 
colleagues have demonstrated the increased burden of hospitalisation for heart failure 
of non-ischaemic aetiology (Teng, et al., 2011). 
 
Atrial fibrillation 
Prevalence and disease burden 
There are no reliable prevalence data for atrial fibrillation (AF) in Australia. North 
American data suggest that the age-adjusted prevalence of AF is lower in women than 
men, but the absolute numbers of men and women with AF are approximately equal 
because women over 75 years outnumber men (Pilote, et al., 2007). 
 
Outcomes 
Studies published during the past 20 years suggest that women with AF are more 
likely than men to experience symptomatic attacks, have a higher frequency of 
recurrences, and show significantly higher heart rates than men during AF (Volgman, 
et al., 2009),  AF also appears to confer a relatively greater risk of stroke in women 
than in men(Pilote, et al., 2007). 
 
Women may have a higher risk of bleeding due to anticoagulation therapy for AF, 
(Pilote, et al., 2007) and in premenopausal women the effect of the menstrual cycle on 
QT intervals must be considered when selecting antiarrhythmic agents (Volgman, et 
al., 2009). 
 
Stroke 
Prevalence and disease burden 
While the age-standardised death rate due to stroke is slightly lower among Australian 
women than men, the absolute number of deaths due to stroke is approximately 50% 
higher in women because over 80% of deaths occur in Australians over 75 years 
(Australian Institute of Health and Welfare, 2008). Age-standardised death rates for 
stroke are declining approximately equally in men and women (Australian Institute of 
Health and Welfare, 2008).  It has been predicted that by 2050, mortality from stroke 
will be 30% higher in women than men (Kurth & Bousser, 2009). 
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Outcomes 
North American and Scottish data show that women with a history of stroke have 
higher hospital readmission rates than men (Pilote, et al., 2007) (Lewsey et al., 2010).  
 
Peripheral arterial disease 
Prevalence and disease burden 
There are no currently no data on the prevalence of peripheral arterial disease (PAD) 
in women in Australia. International studies indicate that the prevalence of PAD 
amongst women ranges from 5.5% to 29%  (Wilbert S. Aronow, 2009; Vavra & 
Kibbe, 2009), increasing with age. Evidence suggests that women may be less likely 
to experience typical claudication symptoms   which may lead to less recognition of 
PAD in women. However, compared to men, it has been demonstrated that women 
with PAD have faster functional decline and experience greater mobility loss 
(McDermott et al., 2011).  
 
Outcomes 
Women with PAD are at significant risk of all-cause and cardiovascular mortality and 
cardiovascular events such as stroke and AMI (  Aronow, Ahmed, Ekundayo, Allman, 
& Ahmed, 2009).. Dutch data indicate that following an initial hospitalisation for 
PAD, 10.4% of women were dead after 1 year and 27.4% at five years; 61.9% of 
deaths in women at 1 year  and 53.7% at 5 years were attributed to cardiovascular 
cause(Vaartjes et al., 2009). Lower intervention rates have been reported for women, 
compared to men (Egorova et al., 2010; Vouyouka et al., 2010).  
 
Part B. What factors might explain CVD sex differences? 
Physiological differences 
Different coronary artery anatomy, hormonal effects on the cardiovascular system and 
body fat distribution may affect women’s and men’s CVD risk. It is well established 
that premenopausal women have a much lower incidence of CHD than age-matched 
men, and that the incidence of CHD among women increases rapidly after menopause 
(Pilote, et al., 2007) (Vaccarino et al, 2011). However, it remains unclear whether the 
influence of menopause on CHD is primarily related to changes in oestrogen levels, or 
to the other age-related risk factors such as hypertension (Gierach et al., 2006). 
Endogenous oestrogen has been thought to confer CVD protection, but oestrogen 
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replacement therapy has not been shown to improve cardiovascular outcomes and is 
not recommended in the primary prevention of CVD in postmenopausal women 
(National Health and Medical Research Council, 2005). 
 
Cardiovascular risk factors in women 
The major risk factors for CVD identified in mixed populations and in men also apply 
to women, and intensive risk-factor modification appears to be effective in countering 
plaque progression women as for men (Blum & Blum, 2009). Data from the 
international INTERHEART study suggest that 94% of population attributable risk in 
women (versus 90% in men) is accounted for by nine risk factors: smoking, raised 
ApoB/ApoA1 ratio, history of hypertension, diabetes, abdominal obesity, 
psychosocial factors, inadequate daily consumption of fruits and vegetables, 
abstinence from alcohol consumption (protective effect associated with regular use), 
and inadequate physical activity.  
 
Overall, the prevalence  of biomedical and lifestyle risk factors are generally similar 
in Australian women and men (Table 1), but marked postmenopausal changes are 
seen in some risk factors, such as lipid profile (Australian Institute of Health and 
Welfare, 2008), North American studies show that premenopausal women have lower 
blood pressure (BP), low-density-lipoprotein (LDL) cholesterol and lower 
plasminogen activator inhibitor type-1, and higher levels of high-density-lipoprotein 
(HDL) cholesterol than men, but that after menopause cardiovascular risk profiles are 
more similar to those of men ( Evangelista & McLaughlin, 2009; Pilote, et al., 2007). 
 
Women experience higher rates of potential psychosocial risk factors such as 
depression, stress associated with family or work, socioeconomic deprivation, and 
adverse early life events (Vaccarino, 2010).  However, the role of psychosocial risk 
factors in CVD among women has not been well evaluated (Vaccarino, 2010) (Low, 
Thurston, & Matthews, 2010).   
 
The degree of risk conferred by individual risk factors and combinations of risk 
factors may differ between the sexes (Table 2). The risk of CVD has been reported to 
increase more steeply in women than in men with each additional risk factor (Oda et 
al., 2006).  
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Evidence bias 
The prevention and management of heart disease in women is largely based on 
strategies developed and tested in men and it is not clear to what extent the findings 
apply to women (Ghali, 2009; Meagher, 2004). Although enrolment of women in 
randomised clinical trials has increased since the 1970s, women remain 
underrepresented cardiovascular clinical trials (Melloni et al., 2010). A recent analysis 
of clinical trials cited by the American Heart Association’s 2007 guidelines for CVD 
prevention in women (Mosca et al., 2007) found that women comprised only 29% of 
patients in heart failure trials, 25% of those in CHD trials and 28% of those in 
hyperlipidaemia trials, and that sex-specific findings were reported in only 31% of 
original trial publications (Melloni, et al., 2010). 
 
 
Male bias in trial sampling may mask differences between sexes in treatment 
responses. A recent meta-analysis concluded that implantable cardioverter-
defibrillator therapy for the primary prevention of sudden cardiac death in women 
does not reduce all-cause mortality (Ghanbari et al., 2009) . 
 
Part C. Which non-biological factors might affect women’s CVD? 
Community knowledge and beliefs 
Lack of recognition of women’s cardiovascular risk may preclude effective 
prevention and management. A 2008 national survey of 1,964 Australian women aged 
30–65 years commissioned by the Heart Foundation in found that:  
• Only 22% were aware that heart disease is the leading cause of death in women. 
• While 95% recognised smoking, poor diet and physical inactivity as CVD risk 
factors, almost two-thirds (65%) did not identify high BP, high cholesterol or 
diabetes as risk factors. 
• More than 50% believed that heart disease was more common amongst men than 
women. 
• There was limited awareness that the risk of heart disease in women increases with 
age, especially after menopause. 
  11 
• A substantial number of women reported they were regularly screened for high BP, 
but were less likely to be assessed for cholesterol or diabetes (National Heart 
Foundation 2008). 
 
A similar lack of awareness of CVD as a major women’s health issue has been 
documented in US women (Ferris, Robertson, Fabunmi, Mosca, & American Heart 
Association, 2005; Mosca et al., 2006). 
 
Gender-based differences in health behaviours 
Delays in seeking care may contribute to poorer outcomes in women, which are not 
entirely explained by the relative older age and associated higher rates of comorbidity 
among the female CVD population. Several investigators have documented evidence 
that women may experience CVD differently from men (Daly et al., 2002; . 
Evangelista, Kawaga-Singer, & Dracup, 2001; Hammond, Salamonson, Davidson, 
Everett, & Andrew, 2007; Lefler, 2004; Nau et al., 2005; Rosenfeld, 2001).  
 
Women are more likely to underestimate their CVD risk than men (Evangelista, et al., 
2001; Hammond, et al., 2007; Lefler, 2004). Women with ACS have been reported to 
rate their cardiac disease as less severe than men, after controlling for other measures 
of cardiac disease severity (Nau, et al., 2005). Women are also significantly less likely 
to report chest pain or discomfort compared with men (Canto, et al., 2007). During 
ACS, women are more likely to delay seeking medical care than men,(Goldberg, 
Gurwitz, & Gore, 1999; O'Donnell, Condell, Begley, & Fitzgerald, 2006; Rosenfeld, 
2001) for reasons that may include attributing symptoms to other causes, fear of 
bothering anyone, embarrassment about a ‘false alarm’ and reluctance to call 
emergency medical services (Dracup, 2007). 
 
Women who have experienced an AMI may be less likely than men to adopt lifestyle 
changes including healthy eating and increasing physical activity, (DiGiacomo, 
Davidson, Zecchin, Lamb, & Daly, 2011; Martin et al., 2005) consistent with weaker 
attribution of their AMI to lifestyle risk factors (Martin, et al., 2005).  Participation 
rates for coronary rehabilitation are lower in women than men (Daly, et al., 2002). An 
Australian study among patients eligible for a structured cardiac rehabilitation 
program after a cardiac event found that only 22% of women participated, compared 
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with 78% of men  (Davidson et al., 2008). Older women experience special barriers to 
adopting exercise in the self-management of CVD, including a low self-rating of their 
ability to undertake physical activity and poor tolerance of physical activity (Lee, 
1993; Moore, 1996).  
 
Sex-based differences in health care 
Misdiagnosis and less aggressive treatment in women have been commonly reported. 
In the Framingham Heart Study cohort, 50% of AMIs in women were unrecognised, 
compared with 33% in men (Murabito, 1995).  Another US study reported that 
women presenting to the emergency department with AMI were more likely to be 
discharged without admission than men, and that those under 55 years were at highest 
risk of misdiagnosis (Pope et al., 2000). 
 
Even after diagnosis, potentially clinically significant differences in treatment have 
been reported. A Canadian report found that, compared with men, women were less 
likely to be treated by a specialist, less likely to be transferred to another facility for 
treatment, and less likely to receive cardiac catheterisation or revascularisation 
(Spurgeon, 2007), It has been hypothesised that adverse outcomes of CHD in women 
compared with those in men might reflect the current focus of treatment on 
obstructive coronary artery disease, and that this model may not apply equally to 
women’s CVD (Shaw, et al., 2009).  
 
Most research investigating sex-based differences in clinical management of CVD has 
focussed on ACS – to the relative neglect of angina, the most common manifestation 
of CHD in women (Vaccarino, 2010) . 
 
Discussion 
Differences in women’s CVD risk, presentation, management and experience 
highlight the need for health professionals to develop chronic disease prevention and 
treatment strategies for women. The National Health and Medical Research Council’s 
2004 Clinical practice guidelines for the management of overweight and obesity in 
adults(National Health and Medical Research Council, 2004) is example of this 
approach, identifying separate strategies for weight loss that work best in women and 
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in men. A gender-specific approach to CVD management is gaining momentum 
internationally, as evidenced by the World Heart Foundation’s Go Red For Women 
campaign, yet identifying the most important messages remain controversial (Canto, 
et al., 2007; Engberding & Wenger, 2008).   
 
Cardiovascular disease is often overlooked as a women’s health issue (Wenger, 2011). 
Australian women need reliable information about their risk for CVD and 
encouragement to engage in healthy behaviours and correct biomedical risk factors, 
respond promptly to symptoms such as heart attack warning signs, and obtain 
appropriate health care when needed. Messages should be tailored for women from 
high-risk groups, including those living outside metropolitan areas,(Sexton & Sexton, 
2000) Aboriginal and Torres Strait Islander women,(Australian Institute of Health and 
Welfare, 2008) and those who are socioeconomically disadvantaged (Turrell, Stanley, 
de Looper, & Oldenburg, 2006). 
 
The Heart Foundation’s Go Red for Women Campaign draws on recent US 
experience demonstrating that women’s knowledge of CVD and their risk can be 
substantially improved by public awareness campaigns (Mochari-Greenberger, Mills, 
Simpson, & Mosca, 2010). Cardiovascular disease prevention will be included in the 
Federal Government planned 10-year national women’s health policy,(Australian 
Government, 2009) which will recognise gender as a basic determinant of health 
affecting health outcomes and health care needs. 
 
Conclusions 
Improvement in the prevention and management of CVD in women will require a 
deeper understanding of women’s needs by the Australian community, health care 
professionals, researchers and government. 
 
 
 
 
 
 
  14 
 
Acknowledgements 
 
Dr Michelle DiGiacomo is supported by an NHMRC Postdoctoral Fellowship, Dr 
Sally Inglis is supported by the National Health and Medical Research Council and 
Heart Foundation of Australia by a Sidney Sax Post-Doctoral Fellowship and Dr 
Newton by a University of Technology Sydney Chancellor's Post Doctoral 
Fellowship.  
 
 
  15 
References 
Access Economics. (2005). The shifting burden of cardiovascular disease. 
Melbourne: Heart Foundation. 
American Heart Association. (2008). Heart disease and stroke statistics – 2008 
update. Dallas: American Heart Association. 
Aronow, W. S. (2009). Peripheral arterial disease in women. Maturitas, 64(4), 204-
211. 
Aronow, W. S., Ahmed, M. I., Ekundayo, O. J., Allman, R. M., & Ahmed, A. (2009). 
A propensity-matched study of the association of peripheral arterial disease 
with cardiovascular outcomes in community-dwelling older adults. The 
American Journal of Cardiology, 103(1), 130-135. 
Australian Bureau of Statistics. (2006). Cardiovascular disease in Australia: a 
snapshot, 2004–05. Catalogue number 4821.0.55.00 Available from 
http://www.abs.gov.au/ausstats/abs@.nsf/mf/4821.0.55.001 
Australian Bureau of Statistics. (2009). Causes of Death, Australia, 2007. Catalogue 
number 3303.0 Available from 
http://www.abs.gov.au/ausstats/abs@.nsf/cat/3303.0 
Australian Government. (2009). Development of A New National Women’s Health 
Policy - Consultation Discussion Paper 2009. Canberra: Commonwealth of 
Australia. 
Australian Institute of Health and Welfare. (2004). Heart, stroke and vascular 
diseases—Australian facts 2004. AIHW Cat. No. CVD 27. Canberra: AIHW 
and National Heart Foundation of Australia (Cardiovascular Disease Series 
No. 22). 
Australian Institute of Health and Welfare. (2008). Australia’s health 2008. Cat. no. 
AUS 99. Canberra: AIHW. 
Bairey Merz, C., Shaw, L., Reis, S., Bittner, V., Kelsey, S., Olson, M., et al. (2006). 
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation 
(WISE) Study: Part II: gender differences in presentation, diagnosis, and 
outcome with regard to gender-based pathophysiology of atherosclerosis and 
macrovascular and microvascular coronary disease. Journal of the American 
College of Cardiology, 47 (3 Suppl), S21-S29. 
Begg, S. J., Vos, T., Barker, B., Stanley, L., & Lopez, A. D. (2008). Burden of disease 
and injury in Australia in the new millennium: measuring health loss from 
diseases, injuries and risk factors. Medical Journal of Australia, 188(1), 36-40. 
Blum, A., & Blum, N. (2009). Coronary artery disease: Are men and women created 
equal? Gender Medicine, 6(3), 410-418. 
Canto, J., Goldberg, R., Hand, M., Bonow, R., Sopko, G., Pepine, C., et al. (2007). 
Symptom presentation of women with acute coronary syndromes: myth vs 
reality. Archives of Internal Medicine, 167(22), 2405-2413. 
Daly, J., Sindone, A., Thompson, D., Hancock, K., Chang, E., & Davidson, P. (2002). 
Barriers to participation in and adherence to cardiac rehabilitation programs: a 
critical literature review. Progress in Cardiovascular Nursing, 17(1), 8-17. 
Davidson, P., Digiacomo, M., Zecchin, R., Clarke, M., Paul, G., Lamb, K., et al. 
(2008). A cardiac rehabilitation program to improve psychosocial outcomes of 
women with heart disease. Journal of Women's Health, 17(1), 123-134. 
DiGiacomo, M., Davidson, P. M., Zecchin, R., Lamb, K., & Daly, J. (2011). Caring 
for Others, but Not Themselves: Implications for Health Care Interventions in 
Women with Cardiovascular Disease. Nursing Research and Practice, 
doi:10.1155/2011/376020. 
  16 
Dracup, K. (2007). The challenge of women and heart disease. Archives of Internal 
Medicine, 167(22), 2396. 
Egorova, N., Vouyouka, A. G., Quin, J., Guillerme, S., Moskowitz, A., Marin, M., et 
al. (2010). Analysis of gender-related differences in lower extremity peripheral 
arterial disease. Journal of Vascular Surgery, 51(2), 372-378. e371. 
Engberding, N., & Wenger, N. (2008). Cardiovascular disease prevention tailored for 
women. Expert Review of Cardiovascular Therapy, 6(8), 1123-1134. 
Evangelista, L., Kawaga-Singer, M., & Dracup, K. (2001). Gender differences in 
health perceptions and meaning in persons living with heart failure. Heart & 
Lung, 30(3), 167-176. 
Evangelista, O., & McLaughlin, M. (2009). Review of cardiovascular risk factors in 
women. Gender Medicine, 6 Suppl 1, 17-36. 
Ferris, A., Robertson, R., Fabunmi, R., Mosca, L., & American Heart Association. 
(2005). American Stroke Association American Heart Association and 
American Stroke Association national survey of stroke risk awareness among 
women. Circulation, 111(10), 1321-1326. 
Ghali, J. K. (2009). Sex, race and ethnicity: providing quality care for elderly patients 
hospitalized with heart failure. Aging Health, 5(2), 171-176. 
Ghanbari, H., Dalloul, G., Hasan, R., Daccarett, M., Saba, S., David, S., et al. (2009). 
Effectiveness of implantable cardioverter-defibrillators for the primary 
prevention of sudden cardiac death in women with advanced heart failure: a 
meta-analysis of randomized controlled trials. Archives of Internal Medicine, 
169(16), 1500-1506. 
Gierach, G., Johnson, B., Bairey Merz, C., Kelsey, S., Bittner, V., Olson, M., et al. 
(2006). Hypertension, menopause, and coronary artery disease risk in the 
Women’s Ischemia Syndrome Evaluation (WISE) study. Journal of the 
American College of Cardiology, 47 (3 Suppl 1), S50-S58. 
Goldberg, R., Gurwitz, J., & Gore, J. (1999). Duration of, and temporal trends (1994-
1999) in, prehospital delay in patients with acute myocardial infarction: the 
second National Registry of Myocardial Infarction. Archives of Internal 
Medicine, 159(18), 2141-2147. 
Guillemin, M. (2004). Heart disease and mid-age women: Focusing on gender and 
age. Health Sociology Review, 13(1), 7-13. 
Hammond, J., Salamonson, Y., Davidson, P., Everett, B., & Andrew, S. (2007). Why 
do women underestimate the risk of cardiac disease? A literature review. 
Australian Critical Care, 20(2), 53-59. 
Kennedy, J., Killip, T., Fisher, L., Alderman, E., Gillespie, M., & Mock, M. (1982). 
The clinical spectrum of coronary artery disease and its surgical and medical 
management, 1974-1979. The Coronary Artery Surgery study. Circulation, 66 
(5 Pt 2), III16-23. 
Kurth, T., & Bousser, M. (2009). Stroke in women: an evolving topic. Stroke, 40(4), 
1027-1028. 
Lee, C. (1993). Factors related to the adoption of exercise among older women. 
Journal of Behavioural Medicine, 16(3), 323-324. 
Lefler, L. (2004). Perceived risk of heart attack: a function of gender? Nursing Forum, 
39(2), 18-26. 
Lerner, D., & Kannel, W. (1986). Patterns of coronary heart disease morbidity and 
mortality in the sexes: a 26-year follow-up of the Framingham population. 
American Heart Journal, 111, 383-390. 
  17 
Lewsey, J., Jhund, P., Gillies, M., Chalmers, J., Redpath, A., Briggs, A., et al. (2010). 
Temporal trends in hospitalisation for stroke recurrence following incident 
hospitalisation for stroke in Scotland. BMC medicine, 8(1), 23. 
Low, C. A., Thurston, R. C., & Matthews, K. A. (2010). Psychosocial factors in the 
development of heart disease in women: current research and future directions. 
Psychosomatic medicine, PSY. 0b013e3181f6934fv3181. 
Martin, R., Johnsen, E., Bunde, J., Bellman, S., Rothrock, N., Weinrib, A., et al. 
(2005). Gender differences in patients' attributions for myocardial infarction: 
implications for adaptive health behaviors. International Journal of 
Behavioural Medicine, 12(1), 39-45. 
Matyal, R. (2008). Newly appreciated pathophysiology of ischemic heart disease in 
women mandates changes in perioperative management: a core review. 
Anesthesia and Analgesia, 107(1), 37-50. 
McDermott, M. M., Ferrucci, L., Liu, K., Guralnik, J. M., Tian, L., Kibbe, M., et al. 
(2011). Women With Peripheral Arterial Disease Experience Faster Functional 
Decline Than Men With Peripheral Arterial Disease. Journal of the American 
College of Cardiology, 57(6), 707. 
Meagher, E. (2004). Addressing cardiovascular disease in women: focus on 
dyslipidemia. Journal of the American Board of Family Practice, 17(6), 424-
437. 
Melloni, C., Berger, J., Wang, T., Gunes, F., Stebbins, A., Pieper, K., et al. (2010). 
Representation of women in randomized clinical trials of cardiovascular 
disease prevention. Circulation. Cardiovascular quality and outcomes, 3(2), 
135-142. 
Milner, K., Funk, M., Richards, S., Wilmes, R., Vaccarino, V., & Krumholz, H. 
(1999). Gender differences in symptom presentation associated with coronary 
heart disease. The American Journal of Cardiology, 84(4), 396-399. 
Mochari-Greenberger, H., Mills, T., Simpson, S. L., & Mosca, L. (2010). Knowledge, 
preventive action, and barriers to cardiovascular disease prevention by race 
and ethnicity in women: An American heart association national survey. 
Journal of Women's Health, 19(7), 1243-1249. 
Moore, S. (1996). Women's views of cardiac rehabilitation programs. Journal of 
Cardiopulmonary Rehabilitation, 16(2), 123-129. 
Mosca, L., Banka, C., Benjamin, E., Berra, K., Bushnell, C., Dolor, R., et al. (2007). 
Evidence-based guidelines for cardiovascular disease prevention in women: 
2007 update. Journal of the American College of Cardiology, 49(11), 1230-
1250. 
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. 
M., et al. (2011). Effectiveness-Based Guidelines for the Prevention of 
Cardiovascular Disease in Women--2011 Update: A Guideline From the 
American Heart Association. Journal of the American College of Cardiology, 
57(12), 1404. 
Mosca, L., Mochari, H., Christian, A., Berra, K., Taubert, K., Mills, T., et al. (2006). 
National study of women's awareness, preventive action, and barriers to 
cardiovascular health. Circulation, 113(4), 525-534. 
Murabito, J. M. (1995). Women and cardiovascular disease: contributions from the 
Framingham Heart Study. Journal of the American Medical Women's 
Association, 50(2), 55. 
Murphy, B., Worcester, M., Higgins, R., Le Grande, M., Larritt, P., & Goble, A. 
(2005). Causal attributions for coronary heart disease among female cardiac 
  18 
patients. Journal of Cardiopulmonary Rehabilitation and Prevention, 25(3), 
135. 
National Health and Medical Research Council. (2004). Clinical practice guidelines 
for the management of overweight and obesity in adults. Canberra: 
Commonwealth of Australia. 
National Heart Foundation (2008) Unpublished data.  
National Health and Medical Research Council. (2005). Hormone replacement 
therapy: a summary of the evidence. Canberra: Australian Government. 
Nau, D., Ellis, J., Kline-Rogers, E., Mallya, U., Eagle, K., & Erickson, S. (2005). 
Gender and perceived severity of cardiac disease: evidence that women are 
"tougher". The American Journal of Medicine, 118(11), 1256-1261. 
Ng, M. (2007). New perspectives on Mars and Venus: unravelling the role of 
androgens in gender differences in cardiovascular biology and disease. Heart 
Lung and Circulation, 16(3), 185-192. 
Norris, C., Ghali, W., Galbraith, P., Graham, M., Jensen, L., Knudtson, M., et al. 
(2004). Women with coronary artery disease report worse health-related 
quality of life outcomes compared to men. Health and Quality of Life 
Outcomes, 2, 21. 
O'Donnell, S., Condell, S., Begley, C., & Fitzgerald, T. (2006). Prehospital care 
pathway delays: gender and myocardial infarction. Journal of Advanced 
Nursing, 53(3), 268-276. 
Oda, E., Abe, M., Kato, K., Watanabe, K., Veeraveedu, P., & Aizawa, Y. (2006). 
Gender differences in correlations among cardiovascular risk factors. Gender 
Medicine, 3(3), 196-205. 
Pilote, L., Dasgupta, K., Guru, V., Humphries, K., McGrath, J., Norris, C., et al. 
(2007). A comprehensive view of sex-specific issues related to cardiovascular 
disease. Canadian Medical Association Journal, 176(6), S1-S44. 
Pope, J., Aufderheide, T., Ruthazer, R., Woolard, R., Feldman, J., Beshansky, J., et al. 
(2000). Missed diagnoses of acute cardiac ischemia in the emergency 
department. New England Journal of Medicine, 342(16), 1163-1170. 
Richey Sharrett, A., Coady, S., Folsom, A., Couper, D., Heiss, G., & ARIC Study. 
(2004). Smoking and diabetes differ in their associations with subclinical 
atherosclerosis and coronary heart disease-the ARIC Study. Atherosclerosis, 
172(1), 143-149. 
Roger, V., Weston, S., Redfield, M., Hellermann-Homan, J., Killian, J., Yawn, B., et 
al. (2004). Trends in heart failure incidence and survival in a community-
based population. Journal of the American Medical Association, 292(3), 344-
530. 
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., 
et al. (2011). Executive Summary: Heart Disease and Stroke Statistics--2011 
Update: A Report From the American Heart Association. Circulation, 123(4), 
459. 
Rosenfeld, A. (2001). Women's risk of decision delay in acute myocardial infarction: 
implications for research and practice. AACN Clinical Issues, 12(1), 29-39. 
Sexton, P., & Sexton, T. (2000). Excess coronary mortality among Australian men 
and women living outside the capital city statistical divisions. Medical Journal 
of Australia, 172(8), 370-374. 
Shaw, L., Bugiardini, R., & Merz, C. (2009). Women and ischemic heart disease: 
evolving knowledge. Journal of the American College of Cardiology, 54(17), 
1561-1575. 
  19 
Sheps, D., Kaufmann, P., Sheffield, D., Light, K., McMahon, R., Bonsall, R., et al. 
(2001). Sex differences in chest pain in patients with documented coronary 
artery disease and exercise-induced ischemia: Results from the PIMI study. 
American Heart Journal, 142(5), 864-871. 
Spurgeon, D. (2007). Gender gap persists in treatment of Canadians after heart attack. 
BMJ (Clinical reseach ed), 334(7588), 280. 
Teng, T. H. K., Hung, J., Knuiman, M., Stewart, S., Arnolda, L., Jacobs, I., et al. 
(2011). Trends in long-term cardiovascular mortality and morbidity in men 
and women with heart failure of ischemic versus non-ischemic aetiology in 
Western Australia between 1990 and 2005. International Journal of 
Cardiology, doi:10.1016/j.physletb.2003.10.071 
Turrell, G., Stanley, L., de Looper, M., & Oldenburg, B. (2006). Health inequalities in 
Australia: Morbidity, health behaviours, risk factors and health service use. 
Health Inequalities Monitoring Series number 2. AIHW Cat. No. PHE 72. 
Canberra: Queensland University of Technology and the Australian Institute 
of Health and Welfare. 
Vaartjes, I., De Borst, G., Reitsma, J., De Bruin, A., Moll, F., Grobbee, D., et al. 
(2009). Long-term survival after initial hospital admission for peripheral 
arterial disease in the lower extremities. BMC cardiovascular disorders, 9(1), 
43. 
Vaccarino, V. (2010). Ischemic heart disease in women: many questions, few facts. 
Circulation. Cardiovascular quality and outcomes, 3(2), 111-115. 
Vavra, A. K., & Kibbe, M. R. (2009). Women and peripheral arterial disease. 
Women's Health, 5(6), 669-683. 
Volgman, A., Manankil, M., Mookherjee, D., & Trohman, R. (2009). Women with 
atrial fibrillation: Greater risk, less attention. 6(3), 419-432. 
Vouyouka, A. G., Egorova, N. N., Salloum, A., Kleinman, L., Marin, M., Faries, P. 
L., et al. (2010). Lessons learned from the analysis of gender effect on risk 
factors and procedural outcomes of lower extremity arterial disease. Journal of 
Vascular Surgery, 52(5), 1196-1202  
Weaver, W., White, H., Wilcox, R., Aylward, P., Morris, D., Guerci, A., et al. (1996). 
Comparisons of characteristics and outcomes among women and men with 
acute myocardial infarction treated with thrombolytic therapy. GUSTO-I 
investigators. Journal of the American Medical Association, 275(10), 777-782. 
Wenger, N. K. (2011). Editorial: Women's Heart Health: A Worldwide Challenge. 
Cardiology in Review, 19(2), 58. 
White, V., & Hayman, J. (2006). Smoking behaviours of Australian secondary 
students in 2005: Drug Strategy Branch, Australian Government Department 
of Health and Ageing. 
Worrall-Carter, L., Jones, T., & Driscoll, A. (2005). The experiences and adjustments 
of women following their first acute myocardial infarction. Contemporary 
Nurse, 19(1-2), 211-221. 
Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., et al. (2004). 
Effect of potentially modifiable risk factors associated with myocardial 
infarction in 52 countries (the INTERHEART study): case-control study. 
Lancet, 364(9438), 937-952. 
 
 
  20 
  
 
 
 
